— Know what they know.
Not Investment Advice
Also trades as: BIM.PA (PAR) · $vol 15M · BMXXY (OTC) · $vol 0M

BMXMF OTC

bioMérieux S.A.
1W: +2.1% 1M: -2.2% 3M: +9.1% YTD: -34.2% 1Y: -37.0% 3Y: -9.9% 5Y: -29.9%
$85.00
-0.31 (-0.36%)
 
Weekly Expected Move ±4.2%
$78 $81 $85 $89 $92
OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 60 · $10.0B mcap · 41M float · 0.0005% daily turnover · Short 98% of daily vol

Cash Flow Trends

Operating Cash Flow
$788M +18.1% ▲
5Y CAGR: +6.2%
Capital Expenditures
$335M +3.1% ▲
5Y CAGR: +3.8%
Free Cash Flow
$453M +40.8% ▲
5Y CAGR: +8.2%
Dividends Paid
$106M -5.8% ▼
Buybacks
$18M +51.6% ▲
Net Change in Cash
$173M +59.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$598M$440M$323M$425M$397M
Depreciation & Amort.$231M$277M$259M$325M$438M
Stock-Based Comp.$12M$13M$20M$23M$0
Change in Working Capital-$36M-$156M-$207M-$51M-$71M
Other Non-Cash Items$24M-$4M$51M-$55M$24M
Operating Cash Flow$811M$475M$445M$667M$788M
— Investing Activities —
Capital Expenditures-$290M-$287M-$338M-$346M-$335M
Acquisitions (Net)-$3M-$43M-$152M-$13M-$125M
Investment Purchases-$400K-$10M$0-$1M-$1000K
Investment Sales$20M$17M$2M$0$0
Other Investing-$34M-$205M$0$600K-$100K
Investing Cash Flow-$307M-$528M-$489M-$360M-$462M
— Financing Activities —
Net Debt Issuance-$50M$14M-$35M-$75M-$30M
Stock Repurchased-$17M-$157M$0-$38M-$18M
Dividends Paid-$73M-$101M-$100M-$100M-$106M
Other Financing$0-$100K$0$0-$1M
Financing Cash Flow-$141M-$244M-$122M-$213M-$155M
Net Change in Cash$416M-$259M-$195M$109M$173M
Cash End of Period$787M$529M$333M$442M$570M
Free Cash Flow$521M$188M$107M$322M$453M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms